Garcia-Vidal, C <br/><br/>
Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention.  [electronic resource] 

 -  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology  Apr 2009 
 - 331-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1435-4373 
<br/><br/><label>Standard No.: </label>10.1007/s10096-008-0628-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abscess--epidemiology<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--adverse effects<br/>Arthritis, Rheumatoid--complications<br/>Cohort Studies<br/>Crohn Disease--complications<br/>Female<br/>Hepatitis B--epidemiology<br/>Herpes Zoster Ophthalmicus--epidemiology<br/>Humans<br/>Immune System--drug effects<br/>Immunosuppression Therapy--adverse effects<br/>Immunosuppressive Agents--adverse effects<br/>Infliximab<br/>Leishmaniasis, Visceral--epidemiology<br/>Male<br/>Middle Aged<br/>Opportunistic Infections--epidemiology<br/>Risk Factors<br/>Statistics, Nonparametric<br/>Tuberculosis--epidemiology